Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ocugen Inc (OCGN)

Ocugen Inc (OCGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,147,311
  • Shares Outstanding, K 199,186
  • Annual Sales, $ 40 K
  • Annual Income, $ -21,820 K
  • 60-Month Beta 4.70
  • Price/Sales 29.49
  • Price/Cash Flow N/A
  • Price/Book 11.71
Trade OCGN with:

Options Overview Details

View History
  • Implied Volatility 128.86%
  • Historical Volatility 65.88%
  • IV Percentile 25%
  • IV Rank 10.32%
  • IV High 359.02% on 02/26/21
  • IV Low 102.36% on 07/29/21
  • Put/Call Vol Ratio 0.29
  • Today's Volume 25,123
  • Volume Avg (30-Day) 53,997
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 257,805
  • Open Int (30-Day) 276,689

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate -0.07
  • Number of Estimates 3
  • High Estimate -0.03
  • Low Estimate -0.11
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.65 +1.95%
on 12/03/21
11.48 -49.83%
on 11/04/21
-6.97 (-54.75%)
since 11/03/21
3-Month
5.65 +1.95%
on 12/03/21
17.65 -67.37%
on 11/03/21
-1.67 (-22.48%)
since 09/03/21
52-Week
0.28 +1,921.05%
on 12/10/20
18.77 -69.31%
on 02/08/21
+5.46 (+1,802.87%)
since 12/03/20

Most Recent Stories

More News
Ocugen, Inc. Provides an Update on its Investigational New Drug Application with U.S. FDA to Initiate a Phase 3 Clinical Trial Evaluating COVID-19 Vaccine Candidate COVAXIN™ (BBV152)

MALVERN, Pa., Nov. 26, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and...

OCGN : 5.76 (-8.72%)
Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and...

OCGN : 5.76 (-8.72%)
Ocugen Provides Business Update and Third Quarter 2021 Financial Results

Conference Call and Webcast Today at 8:30 a.m. ET Emergency Use Authorization application filed with the U.S. FDA for the COVID-19 vaccine...

OCGN : 5.76 (-8.72%)
Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S. FDA to Initiate a Phase 1/2 Clinical Trial Evaluating Gene Therapy Candidate OCU400 (AAV-NR2E3) to Treat Inherited Retinal Degeneration

Modifier gene therapy platform has potential to treat multiple retinal diseases with one product...

OCGN : 5.76 (-8.72%)
Ocugen, Inc. Announces Submission of Emergency Use Authorization Request to the US FDA for Investigational COVID-19 Vaccine COVAXIN™ (BBV152) for Children Ages 2-18 Years

COVAXIN™ (BBV152) was recently awarded Emergency Use Listing by the World Health OrganizationPediatric EUA submission based on immuno-bridging clinical...

OCGN : 5.76 (-8.72%)
Beware of These 2 Meme Stocks in the Healthcare Industry

While subreddit r/WallStreetBets’ huge wagers against short sellers and the resulting short squeezes have helped several stocks skyrocket in price, many of those stocks have witnessed subsequent price...

CLOV : 4.30 (-4.44%)
OCGN : 5.76 (-8.72%)
Ocugen to Host Conference Call on Tuesday, November 9 at 8:30 a.m. ET to Discuss Third Quarter 2021 Financial Results and Provide Business Update

MALVERN, Pa., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and...

OCGN : 5.76 (-8.72%)
Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S. FDA to Initiate a Phase 3 Clinical Trial Evaluating COVID-19 Vaccine Candidate COVAXIN™ (BBV152)

The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population...

OCGN : 5.76 (-8.72%)
Ocugen Reaches Analyst Target Price

In recent trading, shares of Ocugen Inc have crossed above the average analyst 12-month target price of $8.88, changing hands for $9.34/share. When a stock reaches the target an analyst has set, the...

OCGN : 5.76 (-8.72%)
Ocugen Inc. to present pre-clinical data for OCU410 at 2nd Annual Dry AMD Therapeutic Development Conference

MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and...

OCGN : 5.76 (-8.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 6.97
2nd Resistance Point 6.69
1st Resistance Point 6.22
Last Price 5.76
1st Support Level 5.47
2nd Support Level 5.19
3rd Support Level 4.72

See More

52-Week High 18.77
Fibonacci 61.8% 11.71
Fibonacci 50% 9.53
Fibonacci 38.2% 7.35
Last Price 5.76
52-Week Low 0.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar